Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.5 |